348 related articles for article (PubMed ID: 34844152)
1. A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.
Fanelli G; Domschke K; Minelli A; Gennarelli M; Martini P; Bortolomasi M; Maron E; Squassina A; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Baune BT; ; Serretti A; Fabbri C
Eur Neuropsychopharmacol; 2022 Feb; 55():86-95. PubMed ID: 34844152
[TBL] [Abstract][Full Text] [Related]
2. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of antidepressant response: A polygenic approach.
García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
[TBL] [Abstract][Full Text] [Related]
4. Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts.
Ward J; Graham N; Strawbridge RJ; Ferguson A; Jenkins G; Chen W; Hodgson K; Frye M; Weinshilboum R; Uher R; Lewis CM; Biernacka J; Smith DJ
PLoS One; 2018; 13(9):e0203896. PubMed ID: 30240446
[TBL] [Abstract][Full Text] [Related]
5. Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts.
Whalley HC; Adams MJ; Hall LS; Clarke TK; Fernandez-Pujals AM; Gibson J; Wigmore E; Hafferty J; Hagenaars SP; Davies G; Campbell A; Hayward C; Lawrie SM; Porteous DJ; Deary IJ; McIntosh AM
Transl Psychiatry; 2016 Nov; 6(11):e938. PubMed ID: 27801894
[TBL] [Abstract][Full Text] [Related]
6. Discriminating bipolar depression from major depressive disorder with polygenic risk scores.
Liebers DT; Pirooznia M; Ganna A; ; Goes FS
Psychol Med; 2021 Jul; 51(9):1451-1458. PubMed ID: 32063240
[TBL] [Abstract][Full Text] [Related]
7. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
[TBL] [Abstract][Full Text] [Related]
8. Polygenic heterogeneity in antidepressant treatment and placebo response.
Nøhr AK; Forsingdal A; Moltke I; Howes OD; Vitezic M; Albrechtsen A; Dalby M
Transl Psychiatry; 2022 Oct; 12(1):456. PubMed ID: 36309483
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.
; de Moor MH; van den Berg SM; Verweij KJ; Krueger RF; Luciano M; Arias Vasquez A; Matteson LK; Derringer J; Esko T; Amin N; Gordon SD; Hansell NK; Hart AB; Seppälä I; Huffman JE; Konte B; Lahti J; Lee M; Miller M; Nutile T; Tanaka T; Teumer A; Viktorin A; Wedenoja J; Abecasis GR; Adkins DE; Agrawal A; Allik J; Appel K; Bigdeli TB; Busonero F; Campbell H; Costa PT; Davey Smith G; Davies G; de Wit H; Ding J; Engelhardt BE; Eriksson JG; Fedko IO; Ferrucci L; Franke B; Giegling I; Grucza R; Hartmann AM; Heath AC; Heinonen K; Henders AK; Homuth G; Hottenga JJ; Iacono WG; Janzing J; Jokela M; Karlsson R; Kemp JP; Kirkpatrick MG; Latvala A; Lehtimäki T; Liewald DC; Madden PA; Magri C; Magnusson PK; Marten J; Maschio A; Medland SE; Mihailov E; Milaneschi Y; Montgomery GW; Nauck M; Ouwens KG; Palotie A; Pettersson E; Polasek O; Qian Y; Pulkki-Råback L; Raitakari OT; Realo A; Rose RJ; Ruggiero D; Schmidt CO; Slutske WS; Sorice R; Starr JM; St Pourcain B; Sutin AR; Timpson NJ; Trochet H; Vermeulen S; Vuoksimaa E; Widen E; Wouda J; Wright MJ; Zgaga L; Porteous D; Minelli A; Palmer AA; Rujescu D; Ciullo M; Hayward C; Rudan I; Metspalu A; Kaprio J; Deary IJ; Räikkönen K; Wilson JF; Keltikangas-Järvinen L; Bierut LJ; Hettema JM; Grabe HJ; van Duijn CM; Evans DM; Schlessinger D; Pedersen NL; Terracciano A; McGue M; Penninx BW; Martin NG; Boomsma DI
JAMA Psychiatry; 2015 Jul; 72(7):642-50. PubMed ID: 25993607
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk for depression, anxiety and neuroticism are associated with the severity and rate of change in depressive symptoms across adolescence.
Kwong ASF; Morris TT; Pearson RM; Timpson NJ; Rice F; Stergiakouli E; Tilling K
J Child Psychol Psychiatry; 2021 Dec; 62(12):1462-1474. PubMed ID: 33778956
[TBL] [Abstract][Full Text] [Related]
11. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review.
Meerman JJ; Ter Hark SE; Janzing JGE; Coenen MJH
J Affect Disord; 2022 May; 304():1-11. PubMed ID: 35151671
[TBL] [Abstract][Full Text] [Related]
13. Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns.
Oliva V; Fanelli G; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Fabbri C; Serretti A
J Affect Disord; 2023 Jan; 320():534-543. PubMed ID: 36216191
[TBL] [Abstract][Full Text] [Related]
14. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
[TBL] [Abstract][Full Text] [Related]
15. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.
Schubert KO; Thalamuthu A; Amare AT; Frank J; Streit F; Adl M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cearns M; Cervantes P; Chen HC; Chillotti C; Cichon S; Clark SR; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Degenhardt F; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Heilbronner U; Herms S; Hoffmann P; Hou L; Hsu YH; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Maj M; ; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Papiol S; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shekhtman T; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Tekola-Ayele F; Tortorella A; Turecki G; Veeh J; Vieta E; Witt SH; Roberts G; Zandi PP; Alda M; Bauer M; McMahon FJ; Mitchell PB; Schulze TG; Rietschel M; Baune BT
Transl Psychiatry; 2021 Nov; 11(1):606. PubMed ID: 34845190
[TBL] [Abstract][Full Text] [Related]
16. Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness.
Luykx JJ; Loef D; Lin B; van Diermen L; Nuninga JO; van Exel E; Oudega ML; Rhebergen D; Schouws SNTM; van Eijndhoven P; Verwijk E; Schrijvers D; Birkenhager TK; Ryan KM; Arts B; van Bronswijk SC; Kenis G; Schurgers G; Baune BT; Arns M; van Dellen EE; Somers M; Sommer IEC; Boks MP; Gülöksüz S; McLoughlin DM; Dols A; Rutten BPF
Biol Psychiatry; 2022 Mar; 91(6):531-539. PubMed ID: 34955169
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
18. Identifying Pediatric Mood Disorders From Transdiagnostic Polygenic Risk Scores: A Study of Children and Adolescents.
Barnett EJ; Biederman J; Doyle AE; Hess J; DiSalvo M; Faraone SV
J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35452197
[No Abstract] [Full Text] [Related]
19. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study.
Kappelmann N; Czamara D; Rost N; Moser S; Schmoll V; Trastulla L; Stochl J; Lucae S; ; Binder EB; Khandaker GM; Arloth J
Brain Behav Immun; 2021 Jul; 95():256-268. PubMed ID: 33794315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
